INmune Bio Inc. (INMB)
Nasdaq: INMB · Biological Products, (No Diagnostic Substances) · Boca Raton, FL · filing with the SEC since 2017
Who runs INmune Bio Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Moss David J
Chief Executive Officer. First filing Feb 2019, latest Jul 7, 2026, 13 filings in all.
Officers reporting now
3
of 9 people with a filing in the last fifteen months
Directors reporting now
6
12 people on the record since 2019
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Moss David J | Chief Executive Officer | Feb 2019 | Jul 7, 2026 | none |
| Lowdell Mark William | Chief Scientific Officer | Feb 2019 | Jul 7, 2026 | none |
| Ellspermann Cory Randall | CFO | Aug 2025 | Dec 2, 2025 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Clark Ronnie Duane | director | Sep 2026 | Sep 23, 2026 | none |
| Sapirstein James | director | Sep 2026 | Sep 17, 2026 | none |
| Juda Scott | director | Feb 2019 | Jul 7, 2026 | none |
| Allen Marcia | director | Jan 2020 | Dec 2, 2025 | none |
| Ganjei James Kelly | director | Feb 2019 | Dec 2, 2025 | none |
| Schroeder Timothy J | director | Feb 2019 | Dec 2, 2025 | none |
Earlier names on the record5, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.